Artiva Biotherapeutics, Inc. financial statements
Artiva Biotherapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | 10-K |
| Net income | −USD 83.86M | 10-K |
| Cash and equivalents | USD 26.7M | 10-Q |
| Total debt | USD 10.94M | EODHD |
Artiva Biotherapeutics, Inc. financials on 6ix · Artiva Biotherapeutics, Inc. on 6ix